4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-25-014859
CFO & CBO sold 20,689 shares at $0.78 ($16,137)
- CFO & CBO acquired 366,139 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rajavelu Esther CFO & CBO | 2025-02-03 | Grant or award | +266,139 | 645,409 | D | ||
| Rajavelu Esther CFO & CBO | 2025-02-03 | Grant or award | +100,000 | 745,409 | D | ||
| Rajavelu Esther CFO & CBO | 2025-02-05 | Sale | −20,689 | $0.78 | $16,137 | 724,720 | D |
| Open-market sales · 20,689 sh · avg $0.78 · $16,137 | |||||||
Loading xslF345X05/ownership.xml…